Apoptosis, Neuronal Maturation, and Neurotrophin Expression Within Medulloblastoma Nodules

Nodular/desmoplastic medulloblastomas are a well-established histopathological subtype containing reticulin-free nodules or “pale islands” that are comprised of cells with round “neurocytic” nuclei and abundant cytoplasm. Significant neuronal maturation occurs within nodules. We used immunohistochemistry to evaluate neuronal differentiation in the nodules of 6 of these tumors. The neuronal markers NeuN, synaptophysin, and MAP-2 were identified in the “pale islands” of all 6 nodular medulloblastomas examined, and high and medium molecular weight nonphosphorylated neurofilaments were detected in 2 of the 6 cases. We also observed collections of apoptotic cells within nodules. Given the known role of neurotrophin signaling in neuronal maturation and apoptosis, we analyzed immunohistochemically the distribution of neurotrophin receptors TrkA and TrkC and their primary ligands NGF and NT3 in 14 nodular medulloblastomas. TrkA and TrkC were detected in 13 and 10 cases, respectively, and were predominantly localized within nodules. NGF and NT3 were distributed diffusely with some nodular accentuation. The localized expression of Trk receptors within nodules of desmoplastic medulloblastomas suggests neurotrophin signaling is involved in the apoptosis and neuronal differentiation in medulloblastomas. We also examined expression of p53 and BCL-2 in these tumors; both were prominent in internodular regions but only weakly expressed within nodules. Trk receptors, p53, and BCL-2 are all expressed during development of the normal cerebellum. Interestingly, the immunohistochemical expression profile of these proteins in the differentiating nodules of medulloblastomas is in many ways similar to their expression in the developing cerebellum. Thus similar signaling pathways may be operational in cerebellar development and medulloblastoma tumor differentiation.

[1]  W. Kaufmann,et al.  Dendritic cytoskeletal protein expression in mental retardation: an immunohistochemical study of the neocortex in Rett syndrome. , 2000, Cerebral cortex.

[2]  A. Parent,et al.  Characterization of the subventricular zone of the adult human brain: evidence for the involvement of Bcl-2 , 2000, Neuroscience Research.

[3]  J. Trojanowski,et al.  TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Bühren,et al.  Expression of the Neurotrophin Receptor p75NTR in Medulloblastomas Is Correlated with Distinct Histological and Clinical Features: Evidence for a Medulloblastoma Subtype Derived from the External Granule Cell Layer , 2000, Journal of neuropathology and experimental neurology.

[5]  J. Nalbantoglu,et al.  Expression of p27kip1 and p53 in medulloblastoma: relationship with cell proliferation and survival. , 2000, Pathology, research and practice.

[6]  P. Burger,et al.  Medulloblastoma with extensive nodularity: a variant with favorable prognosis. , 1999, Journal of neurosurgery.

[7]  C. Raffel,et al.  Neurotrophins and Trk receptors in primitive neuroectodermal tumor cell lines. , 1999, Neurosurgery.

[8]  D. Schiffer,et al.  Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumors , 1999, Neuroscience Letters.

[9]  Tracey A. Cho,et al.  Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. , 1999, Cancer research.

[10]  D. Born,et al.  Synaptophysin immunocytochemistry with thermal intensification: a marker of terminal axonal maturation in the human fetal nervous system , 1999, Brain and Development.

[11]  M. Israel,et al.  Tumor Cell Apoptosis Present at Diagnosis May Predict Treatment Outcome for Patients With Medulloblastoma , 1998, Journal of pediatric hematology/oncology.

[12]  M. Lookeren Campagne,et al.  Tumor‐suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: Comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto‐oncogene bax , 1998, The Journal of comparative neurology.

[13]  L. Wojnowski,et al.  Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome , 1998, Nature Medicine.

[14]  J. Trojanowski,et al.  Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors , 1998, Acta Neuropathologica.

[15]  Harvey B Sarnat,et al.  Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system 1 Presented at the XIII International Congress of Neuropathology, Perth, Australia, September 7–12, 1997. 1 , 1998, Brain and Development.

[16]  J. Cervós-Navarro,et al.  The Histopathological and Clinical Relevance of Apoptotic Cell Death in Medulloblastomas , 1998, Journal of Neuropathology and Experimental Neurology.

[17]  D. Zagzag,et al.  Apoptosis of undifferentiated progenitors and granule cell precursors in the postnatal human cerebellar cortex correlates with expression of BCL-2, ICE, and CPP32 proteins. , 1998, The Journal of comparative neurology.

[18]  J. Trojanowski,et al.  Neurotrophin signal transduction in medulloblastoma , 1997, Journal of neuroscience research.

[19]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[20]  W. Kaufmann,et al.  Immunoblotting patterns of cytoskeletal dendritic protein expression in human neocortex. , 1997, Molecular and chemical neuropathology.

[21]  T Pietsch,et al.  Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. , 1997, Cancer research.

[22]  D. Kaplan,et al.  Signal transduction by the neutrophin receptors , 1997 .

[23]  J. Martinou,et al.  Susceptibility of Cerebellar Granule Neurons Derived from Bcl‐2‐Deficient and Transgenic Mice to Cell Death , 1997, The European journal of neuroscience.

[24]  L. Rubin,et al.  Bax promotes neuronal cell death and is downregulated during the development of the nervous system. , 1997, Development.

[25]  D. Kaplan,et al.  Signal transduction by the neurotrophin receptors. , 1997, Current opinion in cell biology.

[26]  E. Arenas,et al.  Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo , 1996, The Journal of cell biology.

[27]  J. Trojanowski,et al.  Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system. , 1996, The American journal of pathology.

[28]  S. Wellek,et al.  Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. , 1995, Medical and pediatric oncology.

[29]  P. Distefano,et al.  Differential distribution of exogenous BDNF, NGF, and NT‐3 in the brain corresponds to the relative abundance and distribution of high‐affinity and low‐affinity neurotrophin receptors , 1995, The Journal of comparative neurology.

[30]  S. Pomeroy,et al.  Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Cavenee,et al.  p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. , 1994, Cancer research.

[32]  Iver Petersen,et al.  Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system , 1993, Molecular carcinogenesis.

[33]  A. Frankfurter,et al.  Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands. , 1989, Archives of pathology & laboratory medicine.

[34]  C. Katsetos,et al.  Immunohistochemical and ultrastructural observations on Homer Wright (neuroblastic) rosettes and the "pale islands" of human cerebellar medulloblastomas. , 1988, Human pathology.

[35]  H. Budka,et al.  Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum"). , 1985, Clinical neuropathology.

[36]  Y. Maruyama,et al.  Prognostic factors in medulloblastoma , 1982, American journal of clinical oncology.

[37]  J. Altman,et al.  Postnatal development of the cerebellar cortex in the rat. I. The external germinal layer and the transitional molecular layer , 1972, The Journal of comparative neurology.

[38]  K. Earle,et al.  Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival , 1971, Cancer.

[39]  J. Hallervorden.  [Tumors of the nervous system]. , 1951, Strahlentherapie.

[40]  F. Echlin,et al.  NATURE AND ORIGIN OF SOME TUMORS OF THE CEREBELLUM: MEDULLOBLASTOMA , 1934 .